Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ALLO-647 |
Trade Name | |
Synonyms | ALLO 647|ALLO 647 |
Drug Descriptions |
ALLO-647 is a monoclonal antibody that targets CD52 (CAMPATH-1), which activates host immune response, potentially resulting in the lysis of CD52-positive tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C160787 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ALLO-605 + ALLO-647 + Cyclophosphamide + Fludarabine | ALLO-605 ALLO-647 Cyclophosphamide Fludarabine | 0 | 1 |
ALLO-647 | ALLO-647 | 0 | 0 |
ALLO-647 + ALLO-715 | ALLO-647 ALLO-715 | 0 | 1 |
ALLO-647 + ALLO-715 + Cyclophosphamide + Fludarabine | ALLO-647 ALLO-715 Cyclophosphamide Fludarabine | 0 | 1 |
ALLO-647 + Cyclophosphamide + Fludarabine | ALLO-647 Cyclophosphamide Fludarabine | 0 | 5 |